Clinical trial
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00078247 |
|---|---|
| Title | Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis |
| Official title | Delaying HIV Disease Progression With Punctuated Antiretroviral Therapy in HIV-Associated Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Makerere University |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, Tuberculosis |
| Intervention type | Drug |
| Interventions | Abacavir, Lamivudine, Zidovudine, Tuberculosis treatment |
| Enrollment | 350 |
| Start date | Oct 1, 2004 |
| First posted | Feb 23, 2004 |
| Last update posted | Aug 12, 2010 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: